Fig. 8From: N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancerA m6A-related lncRNA modification of immune responses in CESC patients. B m6A-related immune cells in the tumour microenvironment in CESC patientsBack to article page